Media Room Menu
Month Year
Su | Mo | Tu | We | Th | Fr | Sa |
---|---|---|---|---|---|---|
Month Year
Su | Mo | Tu | We | Th | Fr | Sa |
---|---|---|---|---|---|---|
-
Jun 6, 2016- These data, along with previous Phase 3 studies, will be part of a U.S. regulatory submission for dupilumab, which is on track for Q3 of 2016 -
-
May 25, 2016- FDA decisions on the investigational fixed-ratio combination of basal insulin glargine 100 Units/mL and GLP-1 receptor agonist lixisenatide and investigational lixisenatide anticipated in Q3 2016 -
-
Apr 27, 2016- Collaborations Will Work towards Predicting Medication Adherence -
-
Apr 1, 2016- Dupilumab is first systemic therapy to show positive Phase 3 results in patients with moderate-to-severe atopic dermatitis, a serious, chronic inflammatory skin disease marked by widespread rash, itching and associated psychosocial comorbidities -
-
Mar 29, 2016Pre-clinical immunogenicity and efficacy data published in Journal of Virology
-
Mar 4, 2016Praluent is now covered by most health insurance and Medicare plans
-
Feb 22, 2016- FDA decision anticipated in August 2016 -
-
Feb 12, 2016America's Leading National Consumer Research Survey Ranks ACT Advanced Care #1 in "Oral Care" Category
-
Feb 2, 2016Study Evaluated Adult Patients with Chronic Sinusitis with Nasal Polyposis who did not Respond to Intranasal Corticosteroids
-
Feb 2, 2016Six researchers each receive $1.625 million in "Pathway to Stop Diabetes®" awards
-
Jan 28, 2016- Aims to advance animal health though internet-connected technology and networks -
-
Dec 18, 2015Record-breaking holiday gift drive responds to increased homelessness rates
-
Dec 11, 2015Praluent® is the only PCSK9 inhibitor preferred across UnitedHealth Group formularies, including OptumRx and UnitedHealthcare Commercial, Medicare, and Managed Medicaid formularies
-
Dec 1, 2015New 24 and 32-Packs Designed to Manage Dosage Regimens for both Latent and Active Tuberculosis
-
Nov 20, 2015- A study conducted with 1,500 Americans in July 2015 examined perceived risks of counterfeit medicines[1] -
-
Nov 10, 2015- 74 percent of patients reached their LDL cholesterol goals on 75 mg dose; Of the remaining patients whose dose was adjusted to 150 mg, most achieved their goal -
-
Nov 8, 2015- Data Show Significant Improvement in Signs and Symptoms and Physical Function in Rheumatoid Arthritis Patients who were Inadequate Responders to or Intolerant of TNF-Alpha Inhibitors (TNF-IR) -
-
Oct 29, 2015
-
Sep 29, 2015- First New Drug Application for a GLP-1 receptor agonist to include CV outcomes data -
-
Sep 28, 2015- Crucial vaccination with Raboral V-RG® continues to help protect wildlife and people against this fatal disease
-
Sep 16, 2015New National Council on Aging Survey Shows Many Seniors Underestimate the Seriousness of the Flu, Largely Unaware of Vaccine Options1
-
Sep 14, 2015- LixiLan met primary endpoint showing superior reduction in HbA1c vs Insulin Glargine alone -
-
Aug 31, 2015- Will work together on new digital technology and tools for diabetes -
-
Jul 24, 2015- Praluent available early next week to U.S. patients -
-
Jul 14, 2015- Leading influenza vaccine manufacturer to distribute more than 65 million doses to help protect people six months and older against the flu -
-
Jun 30, 2015Sanofi and Regeneron Engage Academy Award® Winning Documentarian to Capture Behind-the-Scenes Look at Life with an Invisible Condition